ConductScience.org, home

Paper358755

Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.

Wode-Helgodt B and 3 others. Acta Psychiatr Scand, 1978. Cited by 88 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine. Papers, record 358755. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/358755

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
PubMed
Journal
Acta Psychiatr Scand
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
4.75
iCite
Revised in PubMed
2019-08-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wode-Helgodt BB
2Borg SS
3Fyrö BB
4Sedvall GG

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChlorpromazineMajor topic
SchizophreniaMajor topic
Adult
Biopharmaceutics
Clinical Trials as Topic
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Male
Middle Aged
Psychiatric Status Rating Scales
Remission, Spontaneous
Schizophrenic Psychology
Sex Factors

Source PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
29,464,550Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.Clin Pharmacokinet2018https://conductscience.org/library/papers/29464550PubMed
28,407,198Chlorpromazine dose for people with schizophrenia.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28407198PubMed
9,533,984The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.Clin Pharmacokinet1998https://conductscience.org/library/papers/9533984PubMed
7,995,319Smoking and body weight influence the clearance of chlorpromazine.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/7995319PubMed
6,813,900The presence of 7-hydroxychlorpromazine in CSF of chloropromazine-treated patients.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6813900PubMed
6,789,357Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6789357PubMed
6,785,790Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6785790PubMed
6,526,061Haloperidol plasma levels and clinical response in paranoid schizophrenics.Eur Arch Psychiatry Neurol Sci1984https://conductscience.org/library/papers/6526061PubMed
6,111,332Assessment of anti-psychotic drugs.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6111332PubMed
6,110,535Adverse effects of antipsychotic agents.Drugs1981https://conductscience.org/library/papers/6110535PubMed
3,920,702Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3920702PubMed
2,868,820Plasma level monitoring of antipsychotic drugs. Clinical utility.Clin Pharmacokinet1986https://conductscience.org/library/papers/2868820PubMed
2,498,945A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2498945PubMed
1,533,719Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol.Psychopharmacology (Berl)1992https://conductscience.org/library/papers/1533719PubMed
94,992Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.Arch Psychiatr Nervenkr (1970)1979https://conductscience.org/library/papers/94992PubMed
32,861A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS.Arch Psychiatr Nervenkr (1970)1978https://conductscience.org/library/papers/32861PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/358755

GET https://conductscience.org/api/papers/v1/358755/authors